Get the Daily Brief
Latest Biotech News
AI Enhances Diagnostic Precision in Lung Lesions and Medical Coding
Multiple studies showcase artificial intelligence breakthroughs in healthcare diagnostics and administration. A novel machine learning model significantly improves accuracy in LungPro navigational...
Crinetics Pharmaceuticals’ Palsonify Poised to Challenge Acromegaly Market Leaders
Crinetics Pharmaceuticals, having secured FDA approval for Palsonify, an oral once-daily treatment for acromegaly, is positioned to compete with established injectable therapies from pharma giants...
Immuneering’s MEK Inhibitor Atebimetinib Shows Promising Data in Pancreatic Cancer Phase II Trial
Immuneering Corp. announced encouraging updated survival and safety outcomes from its ongoing Phase IIa trial combining oral MEK inhibitor atebimetinib with modified gemcitabine/nab-paclitaxel in...
FDA Clears Crinetics’ Palsonify: Oral Therapy for Acromegaly Sets Up Competition
Crinetics Pharmaceuticals received FDA approval for Palsonify (paltusotine), the first oral first-line therapy for adults with acromegaly, a rare hormonal disorder characterized by excessive...
Advanced Radiation Oncology Research Highlights at ASTRO 2025
Multiple institutions are presenting innovative advances in radiation oncology at the 2025 ASTRO Annual Meeting. University of California centers and others will showcase developments including...
Biocartis Advances Oncology Companion Diagnostics with FDA-Approved Idylla System
Biocartis is repositioning its Idylla system for automated sample-to-answer testing in oncology companion diagnostics. The FDA recently granted premarket approval for the Idylla CDx MSI Test,...
AI and Machine Learning Propel New Frontiers in Diagnostic and Biomedical Research
Cutting-edge AI applications are revolutionizing healthcare and biomedical research. Studies demonstrate that AI systems can autonomously prescribe therapeutics to prevent graft-versus-host...
Novel Immunotherapies Harness Glycan Targeting to Widen Cancer Treatment Scope
Researchers at University of California, Irvine, have developed glycan-dependent T cell recruiters (GlyTRs) that target tumor-associated carbohydrate antigens safely and effectively across...
Gene Editing Innovates with Programmable Bridge Recombinases for Large Genomic Rearrangements
Arc Institute scientists introduced a universal gene editing platform leveraging bridge recombinases to enable precise, megabase-scale DNA rearrangements in human cells. This technology...
NIH Commits $87M to Standardized Organoid Modeling Center, Advancing Alternatives to Animal Testing
The National Institutes of Health awarded $87 million over three years to launch the Standardized Organoid Modeling Center, aiming to accelerate the shift from animal testing towards reproducible...
Cancer Metabolism and RNA Regulation Intersect in Leukemia via IGF2BP3 Protein
UCLA researchers uncovered that Insulin-like Growth Factor 2 mRNA-Binding Protein 3 (IGF2BP3) orchestrates both metabolic reprogramming and RNA methylation to promote leukemia cell proliferation....
Innovations in Digital and Laboratory Infrastructure Foster Rapid Biotech Development
Significant expansions and collaborations are advancing biopharma infrastructure to accelerate early-stage innovation and diagnostic capabilities. Concept Life Sciences expanded its integrated...
Trump Administration Set to Implement Drug Import Tariffs Amid Industry Pushback
The Trump administration announced impending 100% tariffs on branded pharmaceutical imports effective October 1, with exemptions for companies breaking ground on U.S.-based manufacturing...
Crinetics Pharmaceuticals’ FDA Approval for Acromegaly Treatment Signals New Competition
Crinetics Pharmaceuticals has received FDA approval for Palsonify (paltusotine), marking its first approved product and the premier oral first-line therapy for adults with acromegaly who are...
U.S. Pharmaceutical Tariffs: Trump Administration Imposes 100% Import Duties to Boost Domestic Manufacturing
The Trump administration announced a 100% tariff on imports of branded pharmaceutical products effective October 1, with exemptions for companies actively building manufacturing plants in the...
Breakthrough Pan-Cancer Immunotherapy Targets Glycans to Avoid Healthy Tissue Toxicity
Researchers at the University of California, Irvine, have developed glycan-dependent T cell recruiters (GlyTRs), a novel class of immunotherapeutics that selectively target tumor-associated...
Advances in Radiation Oncology Shape Personalized Cancer Treatment at ASTRO 2025
Leading cancer centers including the University of Cincinnati, Sylvester Comprehensive Cancer Center, and MD Anderson Cancer Center revealed significant progress in radiation oncology at the 2025...
NIH Launches $87 Million Standardized Organoid Modeling Center to Accelerate Drug Development Without Animal Testing
The U.S. National Institutes of Health has granted $87 million over three years to establish the Standardized Organoid Modeling Center (SOMC), supporting the transition from traditional animal...
Arc Institute Develops Bridge Recombinase Technology for Programmable Megabase-Scale Genome Editing
Researchers at the Arc Institute have pioneered a universal gene editing platform employing bridge recombinases that facilitates large-scale genomic rearrangements in human cells, including...
Machine Learning and AI Accelerate Medical Imaging and Diagnostics in Oncology and Cardiology
Artificial intelligence and deep learning are increasingly applied to improve diagnostic accuracy and efficiency in medical imaging. Ultromics recently demonstrated enhanced echocardiogram...